Poly(malic acid)-budesonide nanoconjugates embedded in microparticles for lung administration

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Drug Delivery and Translational Research

• Publication date

  2024-03-22

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1007/s13346-024-01571-4PMID 38517568
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of Smoking in Asthma and Chronic Obstructive Pulmonary Disease Overlap.

  2022cited by this paper
• Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles

  2022cited by this paper
• Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease.

  2020cited by this paper
• Pyrazinoic acid-Poly(malic acid) biodegradable nanoconjugate for efficient intracellular delivery

  2019cited by this paper
• Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis

  2019cited by this paper
• Dexamethasone Degradation in Aqueous Medium and Implications for Correction of In Vitro Release from Sustained Release Delivery Systems

  2019cited by this paper
• Sustained therapeutic efficacy of budesonide‐loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose

  2018cited by this paper
• Budesonide nanocrystal-loaded hyaluronic acid microparticles for inhalation: In vitro and in vivo evaluation.

  2018cited by this paper
• Glucocorticoid-loaded liposomes induce a pro-resolution phenotype in human primary macrophages to support chronic wound healing.

  2018cited by this paper
• Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?

  2018cited by this paper
• Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation

  2018cited by this paper
• Inhaled corticosteroids in COPD: friend or foe?

  2018cited by this paper
• Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.

  2017cited by this paper
• Investigation of nanocarriers and excipients for preparation of nanoembedded microparticles.

  2017cited by this paper
• High drug-loading nanomedicines: progress, current status, and prospects

  2017cited by this paper
• Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium

  2017cited by this paper
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)

  2017cited by this paper
• Lungs deposition and pharmacokinetic study of submicron budesonide particles in Wistar rats intended for immediate effect in asthma

  2017cited by this paper
• Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids

  2017cited by this paper
• COPD immunopathology

  2016cited by this paper
• pH-responsive polymer-drug conjugates: Design and progress.

  2016cited by this paper
• Long-term side effects of glucocorticoids

  2016cited by this paper
• Preparation of budesonide nanosuspensions for pulmonary delivery: Characterization, in vitro release and in vivo lung distribution studies

  2016cited by this paper
• Polymer-drug nanoconjugate – an innovative nanomedicine: challenges and recent advancements in rational formulation design for effective delivery of poorly soluble drugs.

  2016cited by this paper
• Disintegration of nano-embedded microparticles after deposition on mucus: A mechanistic study.

  2016cited by this paper
• Revisiting a dogma: the effect of volume exclusion in molecular crowding.

  2015cited by this paper
• Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.

  2015cited by this paper
• Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles.

  2015cited by this paper
• Functionalization of biodegradable hyperbranched poly(α,β-malic acid) as a nanocarrier platform for anticancer drug delivery

  2015influential reference
• Can 'extrafine' dry powder aerosols improve lung deposition?

  2015cited by this paper
• Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles

  2014cited by this paper
• Natural and synthetic poly(malic acid)-based derivates: a family of versatile biopolymers for the design of drug nanocarriers

  2014cited by this paper
• Cellular and molecular mechanisms of chronic obstructive pulmonary disease.

  2014cited by this paper
• Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages.

  2014cited by this paper
• Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.

  2013cited by this paper
• Droplet aerodynamics, cellular uptake, and efficacy of a nebulizable corticosteroid nanosuspension are superior to a micronized dosage form

  2012cited by this paper
• Trojan Microparticles for Drug Delivery

  2012cited by this paper
• Simulated Biological Fluids with Possible Application in Dissolution Testing

  2011cited by this paper
• Mechanistic models facilitate efficient development of leucine containing microparticles for pulmonary drug delivery.

  2011cited by this paper
• Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid

  2011cited by this paper
• Beclomethasone-loaded lipidic nanocarriers for pulmonary drug delivery: preparation, characterization and in vitro drug release.

  2011cited by this paper
• Preparation of Budesonide-Loaded Polycaprolactone Nanobeads by Electrospraying for Controlled Drug Release

  2011cited by this paper
• Aerosol Therapy with Colistin Methanesulfonate: a Biopharmaceutical Issue Illustrated in Rats

  2010cited by this paper
• Evaluation of a Nanoemulsion-Based Formulation for Respiratory Delivery of Budesonide by Nebulizers

  2010cited by this paper
• PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

  2010cited by this paper
• Dexamethasone acetate encapsulation into Trojan particles.

  2008cited by this paper
• Inhaled nanoparticles--a current review.

  2008cited by this paper
• Nanoconjugate based on polymalic acid for tumor targeting.

  2008cited by this paper
• Encapsulation of dexamethasone into biodegradable polymeric nanoparticles.

  2007cited by this paper
• Interpretation of Antibiotic Concentration Ratios Measured in Epithelial Lining Fluid

  2007cited by this paper
• Pharmaceutical Particle Engineering via Spray Drying

  2007cited by this paper
• Inhaling medicines: delivering drugs to the body through the lungs

  2007cited by this paper
• Systemic side effects of inhaled corticosteroids in patients with asthma.

  2006cited by this paper
• The influence of formulation components on the aerosolisation properties of spray-dried powders.

  2005cited by this paper
• Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats.

  2005cited by this paper
• Toxicological hazards of inhaled nanoparticles--potential implications for drug delivery.

  2004cited by this paper
• The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.

  2004cited by this paper
• Control of encapsulation efficiency and initial burst in polymeric microparticle systems

  2004cited by this paper
• Alveolar Macrophages as Orchestrators of COPD

  2004cited by this paper
• Investigation of the degradation mechanisms of poly(malic acid) esters in vitro and their related cytotoxicities on J774 macrophages.

  2004cited by this paper
• Practical synthetic route to functionalized rhodamine dyes.

  2003cited by this paper
• Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.

  2003cited by this paper
• The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method

  2003cited by this paper
• Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

  2002cited by this paper
• Trojan particles: Large porous carriers of nanoparticles for drug delivery

  2002cited by this paper
• IFN-γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38 mapk in a mouse macrophage cell line

  2001influential reference
• Aerodynamic and Geometric Diameters of Airborne Particles

  2001cited by this paper
• IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line.

  2001cited by this paper
• Particulate Interactions in Dry Powder Formulations for Inhalation

  2000cited by this paper
• Enhancement of Small Particle Size Dry Powder Aerosol Formulations using an Ultra Low Density Additive

  1999cited by this paper
• Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

  1999cited by this paper
• Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue.

  1998cited by this paper
• Comparative physicochemical and pharmacokinetic profiles of inhaled beclomethasone dipropionate and budesonide.

  1998cited by this paper
• Molecular mechanisms of steroid action in asthma.

  1996cited by this paper
• A budesonide prodrug accelerates treatment of colitis in rats.

  1994influential reference
• Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.

  1991cited by this paper
• Nanocapsule formation by interfacial polymer deposition following solvent displacement

  1989cited by this paper
• Deposition of particles in the human respiratory tract in the size range 0.005–15 μm

  1986cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• STUDY OF THE EFFECTS OF POLYDISPERSITY OF AEROSOLS ON REGIONAL DEPOSITION IN THE RESPIRATORY TRACT

  1981cited by this paper
• Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.

  1980cited by this paper
• Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics.

  1966cited by this paper
• A HISTOCHEMICAL STUDY OF PHAGOCYTIC AND ENZYMATIC FUNCTIONS OF RABBIT MONONUCLEAR AND POLYMORPHONUCLEAR EXUDATE CELLS AND ALVEOLAR MACROPHAGES

  1963cited by this paper

• Inhalable herbal nanotherapeutics targeting lung carcinoma

  2026cites this paper
• Greenness-assessed RP-HPLC method for budesonide quantification in layer-by-layer polymeric nanoparticles: validation, stability, and controlled release in colonic Delivery

  2025cites this paper
• Poly(malic acid) Nanoconjugates of Pyrazinoic Acid for Lung Delivery in the Treatment of Tuberculosis.

  2024cites this paper
• Alanyl-Glutamine Inhibits the Epithelial-Mesenchymal Transition of Airway Epithelial Cells in Asthmatic Mice via DPP4-SIRT1 Pathway

  2024cites this paper
• [Nanomedicines for the treatment of serious diseases and dual research].

  2024cites this paper